GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Gross Margin %

RAJAF (Cordyceps Sunshine Biotech Holdings Co) Gross Margin % : 90.19% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Cordyceps Sunshine Biotech Holdings Co's Gross Profit for the three months ended in Dec. 2023 was $0.29 Mil. Cordyceps Sunshine Biotech Holdings Co's Revenue for the three months ended in Dec. 2023 was $0.32 Mil. Therefore, Cordyceps Sunshine Biotech Holdings Co's Gross Margin % for the quarter that ended in Dec. 2023 was 90.19%.


The historical rank and industry rank for Cordyceps Sunshine Biotech Holdings Co's Gross Margin % or its related term are showing as below:

RAJAF' s Gross Margin % Range Over the Past 10 Years
Min: 75.47   Med: 81.11   Max: 90.19
Current: 90.19


During the past 4 years, the highest Gross Margin % of Cordyceps Sunshine Biotech Holdings Co was 90.19%. The lowest was 75.47%. And the median was 81.11%.

RAJAF's Gross Margin % is ranked better than
98.8% of 1840 companies
in the Consumer Packaged Goods industry
Industry Median: 25.825 vs RAJAF: 90.19

Cordyceps Sunshine Biotech Holdings Co had a gross margin of 90.19% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cordyceps Sunshine Biotech Holdings Co was 0.00% per year.


Cordyceps Sunshine Biotech Holdings Co Gross Margin % Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co Gross Margin % Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Margin %
- - 75.47 86.75

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
Dec20 Dec21 Sep22 Dec22 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial - - 75.47 - 90.19

Competitive Comparison of Cordyceps Sunshine Biotech Holdings Co's Gross Margin %

For the Packaged Foods subindustry, Cordyceps Sunshine Biotech Holdings Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordyceps Sunshine Biotech Holdings Co's Gross Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cordyceps Sunshine Biotech Holdings Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cordyceps Sunshine Biotech Holdings Co's Gross Margin % falls into.



Cordyceps Sunshine Biotech Holdings Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cordyceps Sunshine Biotech Holdings Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.8 / 0.883
=(Revenue - Cost of Goods Sold) / Revenue
=(0.883 - 0.117) / 0.883
=86.75 %

Cordyceps Sunshine Biotech Holdings Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0.3 / 0.316
=(Revenue - Cost of Goods Sold) / Revenue
=(0.316 - 0.031) / 0.316
=90.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cordyceps Sunshine Biotech Holdings Co  (OTCPK:RAJAF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cordyceps Sunshine Biotech Holdings Co had a gross margin of 90.19% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cordyceps Sunshine Biotech Holdings Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordyceps Sunshine Biotech Holdings Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN
Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines